NCT04263350View on ClinicalTrials.gov

A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

November 12, 2020

Study Completion Date

November 17, 2020

Conditions
Healthy Participants
Interventions
DRUG

Atazanavir/Cobicistat

Specified Dose on Specified Days

DRUG

Reyataz Atazanavir

Specified Dose on Specified Days

DRUG

Cobicistat

Specified Dose on Specified Days

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04263350 - A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time | Biotech Hunter | Biotech Hunter